✦ LIBER ✦

Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis

✍ Scribed by M.J. Elliott; R.N. Maini; M. Feldmann; A. Long-Fox; P. Charles; J.A. Bijl; J.N. Woody

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduction of NOS2 overexpression in rheu

✍ Douglas J. Perkins; E. William St. Clair; Mary A. Misukonis; J. Brice Weinberg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

Randomised double-blind comparison of ch

✍ M.J Elliott; R.N Maini; M Feldmann; J.R Kalden; C Antoni; J.S Smolen; B Leeb; F. 📂 Article 📅 1994 🏛 The Lancet 🌐 English ⚖ 797 KB

Treatment of rheumatoid arthritis with c

✍ Michael J. Elliott; Ravinder N. Maini; Marc Feldmann; Alice Long-Fox; Peter Char 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 1018 KB

Potentiated Antibodies to Tumor Necrosis

✍ L. V. Kozlovskaya; N. A. Mukhin; V. V. Rameev; I. A. Sarkisova; O. I. Epstein 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 294 KB

Efficiency of Potentiated Antibodies to

✍ V. I. Petrov; A. R. Babaeva; E. V. Cherevkova; O. I. Epstein; S. A. Sergeeva 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 402 KB

Self-reported outcomes during treatment

✍ Sidona-Valentina Bala; Kristina Forslind; Marie Edwinson Månsson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB